Search

everythinglearnresearchcommunity

for

Search:↓

Using hemocoagulase with platelet-rich plasma in hip replacement can lessen blood loss and improve healing and blood clotting.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Balding men had lower bone density, while balding women had higher hip bone density.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

People with alopecia areata may have a higher risk of blood clots.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Testosterone therapy increases bone density in older men with low testosterone levels.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Early identification of lupus through skin signs and blood tests is crucial in India.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

New treatments for male hypogonadism are effective and should be personalized.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.